Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 25, 1997
The complex connections between test properties and relevant outcomes: widening the perspective
D L Witte
Clinical Chemistry
|
July 1, 1993
Medically relevant laboratory-performance goals: a listing of the complexities and a call for action
D L Witte
Clinical Chemistry
|
May 1, 1995
Measuring outcomes: why now?
D L Witte
Clinics in Laboratory Medicine
|
June 1, 1993
Wellness testing. Design and experience of an established program
D L Witte
Clinical Chemistry
|
August 1, 1997
Mild liver enzyme abnormalities: eliminating hemochromatosis as cause
D L Witte
Archives of Pathology & Laboratory Medicine
|
April 1, 1993
Matrix effects in therapeutic drug monitoring surveys. Proposed protocol to identify error components and quality improvement opportunities
D L Witte
Clinical Chemistry
|
April 1, 1991
Can serum ferritin be effectively interpreted in the presence of the acute-phase response?
D L Witte
Clinical Chemistry
|
May 1, 1997
Quality for tomorrow: by design or by checking?
C C Garber, D L Witte
Journal of Insurance Medicine (New York, N.Y.)
|
March 4, 1992
The use of mortality studies in underwriting malignancies
B R Kay, D L Witte
American Journal of Clinical Pathology
|
August 1, 1985
Serum 5'-nucleotidase in patients receiving anti-epileptic drugs
C S Fortman, D L Witte
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 25, 1997
The complex connections between test properties and relevant outcomes: widening the perspective
D L Witte
Clinical Chemistry
|
July 1, 1993
Medically relevant laboratory-performance goals: a listing of the complexities and a call for action
D L Witte
Clinical Chemistry
|
May 1, 1995
Measuring outcomes: why now?
D L Witte
Clinics in Laboratory Medicine
|
June 1, 1993
Wellness testing. Design and experience of an established program
D L Witte
Clinical Chemistry
|
August 1, 1997
Mild liver enzyme abnormalities: eliminating hemochromatosis as cause
D L Witte
Archives of Pathology & Laboratory Medicine
|
April 1, 1993
Matrix effects in therapeutic drug monitoring surveys. Proposed protocol to identify error components and quality improvement opportunities
D L Witte
Clinical Chemistry
|
April 1, 1991
Can serum ferritin be effectively interpreted in the presence of the acute-phase response?
D L Witte
Clinical Chemistry
|
May 1, 1997
Quality for tomorrow: by design or by checking?
C C Garber, D L Witte
Journal of Insurance Medicine (New York, N.Y.)
|
March 4, 1992
The use of mortality studies in underwriting malignancies
B R Kay, D L Witte
American Journal of Clinical Pathology
|
August 1, 1985
Serum 5'-nucleotidase in patients receiving anti-epileptic drugs
C S Fortman, D L Witte
Page
of 5